PinnyPeptide

Oxytocin vs Triptorelin

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Oxytocin

Sexual Health

The "bonding hormone" — neuropeptide with established obstetric and exploratory social roles.

Peptide B

Triptorelin

Sexual Health

Long-acting GnRH agonist — FDA-approved for prostate cancer and used in PCT protocols.

Typical vial

2 mg

Typical dose

24-40 IU (intranasal) mcg

Half-life

~3-5 minutes (plasma); longer central effects after intranasal

FDA status

FDA approved as injectable Pitocin for obstetric indications…

Typical vial

2 mg

Typical dose

100-200 (single PCT dose) mcg

Half-life

~3 hours (aqueous); weeks (depot formulation)

FDA status

FDA approved (Trelstar) for advanced prostate cancer. Other …

Oxytocin effects

  • Stimulates uterine contractions (obstetric use)
  • Triggers milk ejection (lactation)
  • May enhance trust and social bonding (research, mixed evidence)
  • Reduces anxiety in some studies (mixed evidence)
  • Modulates pair-bonding behavior
  • Effects on libido and post-coital relaxation (subjective)

Triptorelin effects

  • Initial "flare" of LH/FSH release (week 1-2)
  • Sustained gonadotropin suppression with chronic dosing
  • Clinical: medical castration for prostate cancer
  • Clinical: hormone suppression for endometriosis, fibroids
  • Off-label (PCT): leverage initial flare for HPG axis restart after steroid cycle

Oxytocin side effects

  • Uterine hyperstimulation (obstetric overdose)
  • Water retention / hyponatremia at high obstetric doses
  • Headache, nausea
  • Possible cardiovascular effects (hypotension, tachycardia)
  • Intranasal: nasal irritation, occasional mild euphoria
  • Theoretical: paradoxical anti-social effects in some users (out-group bias)

Triptorelin side effects

  • Initial androgen "flare" (acute prostate symptom worsening)
  • Hot flashes (chronic dosing)
  • Decreased libido and erectile dysfunction (chronic dosing)
  • Bone density loss (long-term chronic use)
  • Mood changes
  • Possible PCT-specific: headache, mild nausea

Oxytocin dosing ranges

Intranasal social/research

24-40 IU · As needed, typically 30-45 min before relevant activity · Acute use

Subcutaneous wellness

5-10 IU · As needed · Acute use

Obstetric (clinical IV)

Per obstetric protocol · Titrated infusion · Per delivery

Triptorelin dosing ranges

Post-cycle therapy (off-label single dose)

100-200 mcg · Single dose at cycle end (SubQ) · One-time

Prostate cancer (clinical, depot)

3.75 mg / 11.25 mg / 22.5 mg · Monthly / quarterly / semi-annual depot IM · Long-term

Endometriosis (clinical, depot)

3.75 mg monthly depot IM · Monthly · 3-6 months typical

Full Oxytocin guide → Full Triptorelin guide →

Oxytocin vs Triptorelin — common questions

What is the difference between Oxytocin and Triptorelin?

Oxytocin: The "bonding hormone" — neuropeptide with established obstetric and exploratory social roles. Typical dose 24-40 IU (intranasal) mcg. Triptorelin: Long-acting GnRH agonist — FDA-approved for prostate cancer and used in PCT protocols. Typical dose 100-200 (single PCT dose) mcg. Both fall under the Sexual Health category.

Can you stack Oxytocin and Triptorelin?

Stacking Oxytocin with Triptorelin is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Oxytocin or Triptorelin?

Oxytocin is typically dosed: As needed, typically 30-45 min before relevant activity for Intranasal social/research; As needed for Subcutaneous wellness; Titrated infusion for Obstetric (clinical IV). Triptorelin is typically dosed: Single dose at cycle end (SubQ) for Post-cycle therapy (off-label single dose); Monthly / quarterly / semi-annual depot IM for Prostate cancer (clinical, depot); Monthly for Endometriosis (clinical, depot).

Are Oxytocin and Triptorelin FDA approved?

Oxytocin: FDA approved as injectable Pitocin for obstetric indications since the 1960s. Intranasal oxytocin not FDA-approved as therapeutic; available via compounding pharmacies. Triptorelin: FDA approved (Trelstar) for advanced prostate cancer. Other indications approved internationally (Decapeptyl, Diphereline).

Related peptide comparisons

kisspeptin-10 vs oxytocinoxytocin vs pt-141kisspeptin-10 vs triptorelinpt-141 vs triptorelin

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free